Moreover, breast cancer is considered hormone-receptor-positive when it possesses estrogen receptor (ER) and/or progesterone receptor (PR), whereas a tumor is considered as triple negative breast cancer when lacking in ER, PR and HER2 expression. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.